Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Devices

Globus Medical, Inc., a medical device company, focuses on the development and commercialization of implants that heal patients with musculoskeletal disorders. Its spine product portfolio includes a range of implant and surgical approach options that can be used to treat degenerative, deformity, tumor, and trauma conditions affecting the spine from the occiput to the sacrum. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and regenerative biologic products, such as allografts and synthetic alternatives that are adjunctive treatments used in combination with stabilizing implant hardware. In addition, it provides motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous distraction devices, and interventional pain management solutions to treat vertebral compression fractures; imaging, navigation, and robotic assisted surgery technology solutions; and hip and knee joint solutions, as well as distributes human cell, tissue, and cellular and tissue based products. Further, the company offers expandable spacer products, which include RISE, RISE-L, CALIBER, CALIBER-L, ALTERA, ELSA, ELSA-ATP, SABLE, MAGNIFY, MAGNIFY-S, FORTIFY, and XPand; CREO thoracolumbar stabilization platform that offers instruments and implants ...
Website: globusmedical.com



Growth: Good revenue growth rate 125.2%, there is acceleration compared to average historical growth rates 27.9%. The revenue growth dynamics is unstable Site traffic for the last 3 months showed a change of +17.2%

Profitability: LTM EBITDA margin is positive, +17.7%. On average the margin is decreasing unsteadily. Gross margin is high, +56.9%. In the last quarter the company beat the estimated EPS, +3.9%. The company was ahead of estimated EPS in 60% of quarters (showing a gain of $0.00 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield -6.3% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 18.6% higher than minimum and 38.2% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 5.2x by EV / Sales multiple , the company can be 14.5% undervalued

Insiders: For the last 3 months insiders sold company shares on $1.0 mln (-0.013% of cap.)

Key Financials (Download financials)

Ticker: GMED
Share price, USD:  (+2.9%)51.95
year average price 53.28  


year start price 58.45 2023-05-07

max close price 62.37 2023-07-18

min close price 43.79 2023-11-13

current price 51.95 2024-05-05
Common stocks: 137 883 000

Dividend Yield:  0.0%
FCF Yield LTM: -6.3%
EV / LTM EBITDA: 25.8x
EV / EBITDA annualized: 22.1x
Last revenue growth (y/y):  125.2%
Last growth of EBITDA (y/y):  14.1%
Historical revenue growth:  27.9%
Historical growth of EBITDA:  33.7%
EV / Sales: 4.6x
Margin (EBITDA LTM / Revenue): 17.7%
Fundamental value created in LTM:
Market Cap ($m): 7 163
Net Debt ($m): 3
EV (Enterprise Value): 7 166
Price to Book: 1.8x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-04-23Zacks Investment Research

GMED vs. PEN: Which Stock Is the Better Value Option?

2024-04-15Zacks Investment Research

Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term

2024-04-04Zacks Investment Research

Globus Medical (GMED) Gains From New Launches Amid Macro Issues

2024-03-13Zacks Investment Research

Here's Why You Should Retain Globus Medical (GMED) Stock Now

2024-02-27Zacks Investment Research

Here's Why Globus Medical (GMED) is a Strong Value Stock

2024-02-26Zacks Investment Research

Here's Why Globus Medical (GMED) is a Strong Momentum Stock

2024-02-21Zacks Investment Research

Globus Medical (GMED) Q4 Earnings Surpass, Margins Down

2024-02-20Seeking Alpha

Globus Medical, Inc. (GMED) Q4 2023 Earnings Call Transcript

2024-02-20Zacks Investment Research

Compared to Estimates, Globus Medical (GMED) Q4 Earnings: A Look at Key Metrics

2024-02-20Zacks Investment Research

Globus Medical (GMED) Q4 Earnings and Revenues Beat Estimates
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol GMED GMED GMED GMED GMED GMED
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2024-02-21 2023-11-07 2023-08-03 2023-05-04 2023-02-21 2022-11-08
acceptedDate 2024-02-20 18:32:27 2023-11-07 17:30:00 2023-08-03 17:15:50 2023-05-04 17:15:46 2023-02-21 17:16:22 2022-11-08 17:16:14
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
revenue 617M 384M 292M 277M 274M 254M
costOfRevenue 265M 135M 76M 71M 71M 65M
grossProfit 351M 248M 215M 206M 204M 189M
grossProfitRatio 0.569 0.647 0.738 0.744 0.743 0.742
researchAndDevelopmentExpenses 52M 29M 21M 21M 20M 19M
generalAndAdministrativeExpenses 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 245M 156M 120M 122M 118M 107M
otherExpenses 297M -475 000 716 000 5M 5M 4M
operatingExpenses 325M 199M 146M 148M 142M 130M
costAndExpenses 591M 335M 222M 219M 213M 195M
interestIncome 0 8M 0 0 0 0
interestExpense 3M 8M 8M 6M 5M 4M
depreciationAndAmortization 71M 14M 18M 21M 17M 18M
ebitda 93M 117M 91M 77M 71M 78M
ebitdaratio 0.151 0.304 0.311 0.278 0.260 0.308
operatingIncome 10M 404 000 66M 56M 54M 60M
operatingIncomeRatio 0.016 0.001 0.227 0.204 0.197 0.235
totalOtherIncomeExpensesNet 25M -54M -3M 7M 8M 2M
incomeBeforeTax 25M 3M 75M 63M 62M 61M
incomeBeforeTaxRatio 0.041 0.007 0.256 0.228 0.226 0.242
incomeTaxExpense 10M 2M 17M 14M 12M 14M
netIncome 15M 998 000 58M 49M 50M 47M
netIncomeRatio 0.024 0.003 0.198 0.178 0.182 0.187
eps 0.110 0.009 0.570 0.490 0.500 0.480
epsdiluted 0.110 0.009 0.570 0.480 0.490 0.470
weightedAverageShsOut 138M 114M 100M 100M 100M 100M
weightedAverageShsOutDil 139M 115M 102M 102M 102M 101M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Balance Sheet Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol GMED GMED GMED GMED GMED GMED
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2024-02-21 2023-11-07 2023-08-03 2023-05-04 2023-02-21 2022-11-08
acceptedDate 2024-02-20 18:32:27 2023-11-07 17:30:00 2023-08-03 17:15:50 2023-05-04 17:15:46 2023-02-21 17:16:22 2022-11-08 17:16:14
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
cashAndCashEquivalents 467M 280M 306M 218M 150M 134M
shortTermInvestments 50M 189M 306M 287M 296M 271M
cashAndShortTermInvestments 518M 469M 613M 504M 446M 405M
netReceivables 505M 496M 242M 226M 217M 209M
inventory 848M 905M 336M 321M 299M 282M
otherCurrentAssets 45M 48M 20M 19M 21M 24M
totalCurrentAssets 1 915M 1 917M 1 210M 1 070M 983M 920M
propertyPlantEquipmentNet 647M 702M 248M 245M 244M 236M
goodwill 1 435M 1 122M 199M 199M 197M 182M
intangibleAssets 925M 1 262M 55M 59M 64M 54M
goodwillAndIntangibleAssets 2 359M 2 384M 254M 258M 261M 236M
longTermInvestments 75M 276M 392M 480M 496M 504M
taxAssets 11M 7M 62M 51M 49M 45M
otherNonCurrentAssets 79M 69M 47M 45M 43M 36M
totalNonCurrentAssets 3 171M 3 439M 1 002M 1 079M 1 093M 1 057M
otherAssets 0 0 0 0 0 0
totalAssets 5 086M 5 356M 2 212M 2 150M 2 076M 1 977M
accountPayables 57M 87M 34M 40M 36M 32M
shortTermDebt 12M 13M 2M 0 0 0
taxPayables 4M 34M 12M 16M 990 000 14M
deferredRevenue 18M 18M 15M 14M 14M 12M
otherCurrentLiabilities 305M 310M 105M 114M 109M 101M
totalCurrentLiabilities 392M 429M 155M 168M 159M 145M
longTermDebt 417M 510M 0 0 0 0
deferredRevenueNonCurrent 91M 0 0 0 2M 2M
deferredTaxLiabilitiesNonCurrent 84M 132M 5M 1M 2M 2M
otherNonCurrentLiabilities 103M 98M 67M 66M 67M 23M
totalNonCurrentLiabilities 696M 740M 72M 67M 71M 67M
otherLiabilities 0 0 0 0 0 0
capitalLeaseObligations 91M 113M 0 0 0 0
totalLiabilities 1 088M 1 169M 227M 235M 230M 212M
preferredStock 0 0 0 0 0 0
commonStock 136 000 140 000 100 000 100 000 100 000 99 000
retainedEarnings 1 137M 1 348M 1 347M 1 289M 1 240M 1 190M
accumulatedOtherComprehensiveIncomeLoss -10M -19M -19M -19M -25M -32M
othertotalStockholdersEquity 2 871M 2 858M 657M 645M 631M 606M
totalStockholdersEquity 3 998M 4 187M 1 985M 1 915M 1 846M 1 764M
totalEquity 3 998M 4 187M 1 985M 1 915M 1 846M 1 764M
totalLiabilitiesAndStockholdersEquity 5 086M 5 356M 2 212M 2 150M 2 076M 1 977M
minorityInterest 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 5 086M 5 356M 2 212M 2 150M 2 076M 1 977M
totalInvestments 126M 465M 698M 767M 791M 775M
totalDebt 520M 523M 0 0 0 0
netDebt 53M 243M -306M -218M -150M -134M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Cash Flow Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol GMED GMED GMED GMED GMED GMED
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2024-02-21 2023-11-07 2023-08-03 2023-05-04 2023-02-21 2022-11-08
acceptedDate 2024-02-20 18:32:27 2023-11-07 17:30:00 2023-08-03 17:15:50 2023-05-04 17:15:46 2023-02-21 17:16:22 2022-11-08 17:16:14
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
netIncome 15M 998 000 58M 49M 50M 47M
depreciationAndAmortization 71M 37M 18M 18M 17M 18M
deferredIncomeTax -12M -35M -7M -4M -5M -9M
stockBasedCompensation 12M 23M 9M 9M 9M 8M
changeInWorkingCapital -45M -2M -48M -21M -15M -33M
accountsReceivables -13M -9M -18M -10M -5M -16M
inventory -11M -20M -16M -22M -13M -17M
accountsPayables -6M -5M -7M 4M 4M -2M
otherWorkingCapital -15M 33M -7M 7M -1M 2M
otherNonCashItems 63M 26M 6M 2M 9M 2M
netCashProvidedByOperatingActivities 105M 50M 35M 53M 64M 33M
investmentsInPropertyPlantAndEquipment -23M -22M -18M -16M -18M -12M
acquisitionsNet 0 -293M 4M -3M -30M 0
purchasesOfInvestments 0 -19M -12M -69M -97M -143M
salesMaturitiesOfInvestments 343M 253M 82M 99M 86M 92M
otherInvestingActivites 343M 234M -4M 0 0 0
netCashUsedForInvestingActivites 321M -81M 52M 11M -60M -63M
debtRepayment 0 0 0 0 0 0
commonStockIssued 1M 3M 0 5M 42M 0
commonStockRepurchased -226M 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0
otherFinancingActivites -13M -2M 1M -2M -28M 13M
netCashUsedProvidedByFinancingActivities -237M 1M 1M 3M 14M 13M
effectOfForexChangesOnCash -347 000 2M 433 000 -26 000 -839 000 479 000
netChangeInCash 188M -27M 89M 67M 16M -17M
cashAtEndOfPeriod 467M 280M 306M 218M 150M 134M
cashAtBeginningOfPeriod 280M 306M 218M 150M 134M 151M
operatingCashFlow 105M 50M 35M 53M 64M 33M
capitalExpenditure -23M -22M -18M -16M -18M -12M
freeCashFlow 82M 29M 17M 37M 46M 21M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Earning call transcript

2023 q4
2024-02-20 ET (fiscal 2023 q4)
2023 q3
2023-11-07 ET (fiscal 2023 q3)
2023 q2
2023-08-03 ET (fiscal 2023 q2)
2023 q1
2023-05-04 ET (fiscal 2023 q1)
2022 q4
2023-02-21 ET (fiscal 2022 q4)
2022 q3
2022-11-08 ET (fiscal 2022 q3)
2022 q2
2022-08-04 ET (fiscal 2022 q2)
2022 q1
2022-05-10 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-02-20 21:15 ET
Globus Medical Reports Fourth Quarter and Full Year 2023 Results
2024-02-13 22:17 ET
Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
2024-02-09 10:15 ET
CapitalGainsReport Sector Spotlight: Orthobiologics Watchlist (ORHB, ZBH, GMED, SYK)
2024-02-05 21:30 ET
Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer
2024-01-10 21:30 ET
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
2023-12-19 10:00 ET
4 Orthobiologic Stocks Set To Soar In 2024
2023-11-07 21:15 ET
Globus Medical Reports Third Quarter 2023 Results
2023-10-24 20:30 ET
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
2023-10-24 11:00 ET
Five-Year Study Outcomes of the NuVasive Simplify Cervical Disc were Presented at the North American Spine Society 38th Annual Meeting
2023-10-10 11:00 ET
Twenty Years of the NuVasive XLIF Procedure Celebrated at the Society for Minimally Invasive Spine Surgery 2023 Annual Forum
2023-09-27 11:00 ET
Globus Medical and NuVasive to Sponsor and Participate at EUROSPINE 2023
2023-09-07 11:00 ET
NuVasive Specialized Orthopedics Launches Precice Bone Transport in International Markets
2023-09-01 12:33 ET
Globus Medical Completes Merger with NuVasive
2023-08-28 21:41 ET
Goosehead Insurance and Jackson Financial Set to Join S&P SmallCap 600
2023-08-03 20:30 ET
Globus Medical Reports Second Quarter 2023 Results
2023-07-31 12:30 ET
Globus Medical Announces Launch of the MARVEL™ Growing Rod System, the company’s first product designed specifically for early onset scoliosis
2023-07-13 20:30 ET
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
2023-05-15 20:30 ET
Globus Medical Announces FDA Approval for its Non-Fusion Scoliosis Correction System, the Latest Advancement for Young Patients with Idiopathic Scoliosis
2023-05-04 20:15 ET
Globus Medical Reports First Quarter 2023 Results
2023-04-27 23:08 ET
Globus Medical Shareholders Approve Share Issuance for Merger with NuVasive
2023-04-27 15:30 ET
NuVasive Shareholders Approve Merger Agreement with Globus Medical
2023-04-19 21:15 ET
Globus Medical Schedules First Quarter Earnings Release and Conference Call
2023-04-17 17:57 ET
Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending NuVasive Shareholders Vote "FOR" the Proposed Merger with Globus Medical
2023-04-14 18:21 ET
Leading Independent Proxy Advisory Firm ISS Recommends NuVasive Shareholders Vote "FOR" the Proposed Merger with Globus Medical
2023-02-21 21:15 ET
Globus Medical Reports Fourth Quarter and Full Year 2022 Results
2023-02-09 12:00 ET
Globus Medical and NuVasive to Combine in All-Stock Transaction to Create Innovative Global Musculoskeletal Company Focused on Patient Care
2023-02-02 21:30 ET
Globus Medical Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call
2022-11-17 13:30 ET
Globus Medical Partners with the UK’s NHS to Provide Hospitals with Surgical Robotic Navigation Technology
2022-11-08 21:15 ET
Globus Medical Reports Third Quarter 2022 Results
2022-10-19 20:30 ET
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
2022-08-04 20:15 ET
Globus Medical Reports Second Quarter 2022 Results
2022-07-18 20:30 ET
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
2022-05-18 20:30 ET
Globus Medical Announces First Surgeries Using Excelsius3D™
2022-05-10 20:15 ET
Globus Medical Reports First Quarter 2022 Results
2022-04-21 20:17 ET
Globus Medical Schedules First Quarter Earnings Release and Conference Call
2022-04-21 20:15 ET
Globus Medical Reports CEO Transition and Preliminary First Quarter 2022 Sales Results
2022-03-04 21:57 ET
Globus Medical Announces the Expansion of its Share Repurchase Program
2022-02-17 21:20 ET
Globus Medical Reports Fourth Quarter and Full Year 2021 Results
2022-01-27 21:30 ET
Globus Medical Schedules Fourth Quarter and Full Year 2021 Earnings Release and Conference Call
2021-11-04 20:15 ET
Globus Medical Reports Third Quarter 2021 Results
2021-10-19 20:30 ET
Globus Medical Premieres ANTHEM® Mini Fragment Fracture System at Orthopaedic Trauma Association Meeting
2021-10-14 21:01 ET
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
2021-10-13 20:30 ET
Globus Medical Files Suit Against Life Spine for IP Infringement
2021-09-28 14:11 ET
Globus Medical to Participate in North American Spine Society Annual Meeting
2021-09-27 20:30 ET
Globus Medical Announces First ExcelsiusGPS® Cranial Surgery
2021-08-16 20:30 ET
Globus Medical Announces FDA 510(k) Clearance for Excelsius3D™
2021-08-04 20:15 ET
Globus Medical Reports Second Quarter 2021 Results
2021-07-16 12:30 ET
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
2021-07-15 20:30 ET
Globus Medical Announces Completion of 20,000 Procedures Utilizing ExcelsiusGPS®
2021-05-04 20:15 ET
Globus Medical Reports First Quarter 2021 Results
2021-04-21 20:30 ET
Globus Medical Schedules First Quarter Earnings Release and Conference Call
2021-04-15 20:30 ET
Globus Medical Announces First Surgeries with Revolutionary CREO ONE™ Robotic Screw
2021-02-17 21:15 ET
Globus Medical Reports Fourth Quarter and Full Year 2020 Results
2021-01-28 21:30 ET
Globus Medical Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call
2020-12-09 21:30 ET
Globus Medical Trauma Division Awarded Purchasing Agreement with Premier Inc.
2020-11-12 21:30 ET
Globus Medical Announces First Surgeries with ExcelsiusGPS® Interbody Solutions
2020-10-28 20:15 ET
Globus Medical Reports Third Quarter 2020 Results
2020-10-16 20:30 ET
Globus Medical Schedules Third Quarter 2020 Earnings Release and Conference Call
2020-10-05 20:30 ET
Globus Medical to Participate as Platinum Sponsor at North American Spine Society Annual Meeting
2020-08-05 20:15 ET
Globus Medical Reports Second Quarter 2020 Results
2020-07-21 20:15 ET
Globus Medical Schedules Second Quarter 2020 Earnings Release and Conference Call
2020-05-07 20:15 ET
Globus Medical Reports First Quarter 2020 Results
2020-04-16 20:30 ET
Globus Medical Schedules First Quarter 2020 Earnings Release and Conference Call
2020-03-11 21:40 ET
Globus Medical Announces $200 Million Share Repurchase Program
2020-02-20 21:15 ET
Globus Medical Reports Fourth Quarter and Full Year 2019 Results
2020-02-06 21:30 ET
Globus Medical Schedules Fourth Quarter and Full Year 2019 Earnings Release and Conference Call
2020-02-04 21:30 ET
Globus Medical Announces First Case with Next Generation 3D Printed Spine Implant
2020-01-08 21:30 ET
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
2019-12-13 21:15 ET
Globus Medical Announces Board of Director Addition and Departure
2019-11-06 21:15 ET
Globus Medical Reports Third Quarter 2019 Results

SEC forms

Show financial reports only

SEC form 10
2024-02-21 00:00 ET
Globus Medical published news for 2023 q4
SEC form 10
2024-02-20 18:32 ET
Globus Medical published news for 2023 q4
SEC form 8
2024-02-20 16:35 ET
Globus Medical published news for 2023 q4
SEC form 8
2024-02-20 16:35 ET
Globus Medical reported for 2023 q4
SEC form 8
2024-01-10 00:00 ET
Globus Medical published news for 2023 q4
SEC form 8
2024-01-10 00:00 ET
Globus Medical published news for 2023 q4
SEC form 10
2023-11-07 17:30 ET
Globus Medical reported for 2023 q3
SEC form 8
2023-11-07 16:19 ET
Globus Medical reported for 2023 q3
SEC form 10
2023-11-07 00:00 ET
Globus Medical published news for 2023 q3
SEC form 10
2023-08-03 17:15 ET
Globus Medical reported for 2023 q2
SEC form 6
2023-08-03 16:20 ET
Globus Medical reported for 2023 q2
SEC form 10
2023-08-03 00:00 ET
Globus Medical published news for 2023 q2
SEC form 8
2023-08-03 00:00 ET
Globus Medical published news for 2023 q2
SEC form 6
2023-06-08 16:15 ET
Globus Medical published news for 2023 q1
SEC form 8
2023-05-04 00:00 ET
Globus Medical published news for 2023 q1
SEC form 10
2023-05-04 00:00 ET
Globus Medical published news for 2023 q1
SEC form 6
2023-04-17 17:02 ET
Globus Medical published news for 2023 q1
SEC form 6
2023-04-03 17:25 ET
Globus Medical published news for 2023 q1
SEC form 6
2023-03-16 17:17 ET
Globus Medical published news for 2022 q4
SEC form 10
2023-02-21 17:16 ET
Globus Medical reported for 2022 q4
SEC form 6
2023-02-21 16:20 ET
Globus Medical published news for 2022 q4
SEC form 8
2023-02-21 00:00 ET
Globus Medical reported for 2022 q4
SEC form 10
2023-02-21 00:00 ET
Globus Medical reported for 2022 q4
SEC form 6
2023-02-09 17:22 ET
Globus Medical published news for 2022 q4
SEC form 6
2023-02-09 07:34 ET
Globus Medical published news for 2022 q4
SEC form 8
2023-02-09 00:00 ET
Globus Medical published news for 2022 q4
SEC form 10
2022-11-08 17:16 ET
Globus Medical reported for 2022 q3
SEC form 6
2022-11-08 16:20 ET
Globus Medical published news for 2022 q3
SEC form 8
2022-11-08 00:00 ET
Globus Medical reported for 2022 q3
SEC form 10
2022-11-08 00:00 ET
Globus Medical reported for 2022 q3
SEC form 10
2022-08-04 17:01 ET
Globus Medical reported for 2022 q2
SEC form 6
2022-08-04 16:20 ET
Globus Medical published news for 2022 q2
SEC form 8
2022-08-04 00:00 ET
Globus Medical reported for 2022 q2
SEC form 10
2022-08-04 00:00 ET
Globus Medical reported for 2022 q2
SEC form 6
2022-06-03 16:00 ET
Globus Medical published news for 2022 q1
SEC form 10
2022-05-10 17:17 ET
Globus Medical reported for 2022 q1
SEC form 6
2022-05-10 16:17 ET
Globus Medical published news for 2022 q1
SEC form 8
2022-05-10 00:00 ET
Globus Medical reported for 2022 q1
SEC form 10
2022-05-10 00:00 ET
Globus Medical reported for 2022 q1
SEC form 6
2022-04-21 16:30 ET
Globus Medical published news for 2022 q1
SEC form 6
2022-04-21 16:20 ET
Globus Medical published news for 2022 q1
SEC form 8
2022-04-21 00:00 ET
Globus Medical published news for 2022 q1
SEC form 6
2022-03-04 17:13 ET
Globus Medical published news for 2021 q4
SEC form 10
2022-02-17 17:22 ET
Globus Medical published news for 2021 q4
SEC form 6
2022-02-17 16:17 ET
Globus Medical published news for 2021 q4
SEC form 10
2022-02-17 00:00 ET
Globus Medical published news for 2021 q4
SEC form 8
2022-02-17 00:00 ET
Globus Medical published news for 2021 q4
SEC form 10
2021-11-04 17:11 ET
Globus Medical published news for 2021 q3
SEC form 6
2021-11-04 16:20 ET
Globus Medical published news for 2021 q3
SEC form 10
2021-11-04 00:00 ET
Globus Medical published news for 2021 q3
SEC form 8
2021-11-04 00:00 ET
Globus Medical published news for 2021 q3
SEC form 10
2021-08-04 16:28 ET
Globus Medical published news for 2021 q2
SEC form 6
2021-08-04 16:19 ET
Globus Medical published news for 2021 q2
SEC form 10
2021-08-04 00:00 ET
Globus Medical published news for 2021 q2
SEC form 8
2021-08-04 00:00 ET
Globus Medical published news for 2021 q2
SEC form 6
2021-06-04 16:30 ET
Globus Medical published news for 2021 q1
SEC form 10
2021-05-04 16:27 ET
Globus Medical published news for 2021 q1
SEC form 6
2021-05-04 16:19 ET
Globus Medical published news for 2021 q1
SEC form 10
2021-05-04 00:00 ET
Globus Medical published news for 2021 q1
SEC form 8
2021-05-04 00:00 ET
Globus Medical published news for 2021 q1
SEC form 6
2021-04-22 16:09 ET
Globus Medical published news for 2021 q1
SEC form 10
2021-02-17 17:15 ET
Globus Medical published news for 2020 q4
SEC form 6
2021-02-17 16:20 ET
Globus Medical published news for 2020 q4
SEC form 10
2020-10-28 16:43 ET
Globus Medical published news for 2020 q3
SEC form 6
2020-10-28 16:20 ET
Globus Medical published news for 2020 q3